250 related articles for article (PubMed ID: 1361372)
1. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation.
Inghirami G; Macri L; Cesarman E; Chadburn A; Zhong J; Knowles DM
Blood; 1994 Jun; 83(12):3581-90. PubMed ID: 8204884
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
Hatta Y; Koeffler HP
Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction.
Chadburn A; Athan E; Wieczorek R; Knowles DM
Blood; 1991 Jun; 77(11):2419-30. PubMed ID: 2039822
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.
Yamato K; Oka T; Hiroi M; Iwahara Y; Sugito S; Tsuchida N; Miyoshi I
Jpn J Cancer Res; 1993 Jan; 84(1):4-8. PubMed ID: 8449826
[TBL] [Abstract][Full Text] [Related]
6. p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24.
Lanza C; Gaidano G; Cimino G; Lo Coco F; Basso G; Sainati L; Pastore C; Nomdedeu J; Volpe G; Parvis G
Leukemia; 1995 Jun; 9(6):955-9. PubMed ID: 7596184
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma).
Matolcsy A; Inghirami G; Knowles DM
Blood; 1994 Mar; 83(5):1363-72. PubMed ID: 8118038
[TBL] [Abstract][Full Text] [Related]
8. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
[TBL] [Abstract][Full Text] [Related]
9. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
10. Genetic alteration of p53 in some patients with adult T-cell leukemia.
Nagai H; Kinoshita T; Imamura J; Murakami Y; Hayashi K; Mukai K; Ikeda S; Tobinai K; Saito H; Shimoyama M
Jpn J Cancer Res; 1991 Dec; 82(12):1421-7. PubMed ID: 1778765
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.
Sugimoto KJ; Kawamata N; Sakajiri S; Oshimi K
Jpn J Cancer Res; 2002 Nov; 93(11):1270-7. PubMed ID: 12460470
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of cutaneous B- and T-cell lymphomas.
Neri A; Fracchiolla NS; Roscetti E; Garatti S; Trecca D; Boletini A; Perletti L; Baldini L; Maiolo AT; Berti E
Blood; 1995 Oct; 86(8):3160-72. PubMed ID: 7579411
[TBL] [Abstract][Full Text] [Related]
13. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes and tumor-suppressor genes.
Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC
Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442
[TBL] [Abstract][Full Text] [Related]
15. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.
Cesarman E; Inghirami G; Chadburn A; Knowles DM
Am J Pathol; 1993 Sep; 143(3):845-56. PubMed ID: 8103295
[TBL] [Abstract][Full Text] [Related]
16. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
[TBL] [Abstract][Full Text] [Related]
17. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.
Matsushima AY; Cesarman E; Chadburn A; Knowles DM
Am J Pathol; 1994 Mar; 144(3):573-84. PubMed ID: 8129043
[TBL] [Abstract][Full Text] [Related]
18. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders.
Gaidano G; Guerrasio A; Serra A; Carozzi F; Cambrin GR; Petroni D; Saglio G
Leukemia; 1993 Jul; 7(7):946-53. PubMed ID: 8321046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
